<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">influenza </span>
   <span class="font26">mice </span>
   <span class="font25">AAV </span>
   <span class="font24">Ra-B </span>
   <span class="font22">:–. </span>
   <span class="font19">mouse </span>
   <span class="font19">(Figure </span>
   <span class="font18">virus </span>
   <span class="font17">(). </span>
   <span class="font17">antibody </span>
   <span class="font16">given </span>
   <span class="font16">days </span>
   <span class="font15">antibodies </span>
   <span class="font15">challenge </span>
   <span class="font15">expression </span>
   <span class="font15">single </span>
   <span class="font15">using </span>
   <span class="font15">protection </span>
   <span class="font15">delivery </span>
   <span class="font15">domain </span>
   <span class="font15">gene </span>
   <span class="font15">neutralizing </span>
   <span class="font14">fusion </span>
   <span class="font14">shown </span>
   <span class="font14">(Sigma </span>
   <span class="font14">Ra-B, </span>
   <span class="font14">immune </span>
   <span class="font14">serum </span>
   <span class="font14">{border-style </span>
   <span class="font14">levels </span>
   <span class="font14">nanobody </span>
   <span class="font14">study </span>
   <span class="font14">binding </span>
   <span class="font14">px;} </span>
   <span class="font14">sera </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">Mice </span>
   <span class="font13">PBS </span>
   <span class="font13">viral </span>
   <span class="font13">cells </span>
   <span class="font13">vivo </span>
   <span class="font13">(v/v) </span>
   <span class="font13">infection </span>
   <span class="font13">neutralization </span>
   <span class="font13">efficacy </span>
   <span class="font13">transgene </span>
   <span class="font13">vector </span>
   <span class="font12">ADCC </span>
   <span class="font12">Ra-B-Fc </span>
   <span class="font12">did </span>
   <span class="font12">different </span>
   <span class="font12">encoding </span>
   <span class="font12">expressing </span>
   <span class="font12">groups </span>
   <span class="font12">human </span>
   <span class="font12">vectors </span>
   <span class="font12">μg/mL </span>
   <span class="font12">Ra-B-mIgGa </span>
   <span class="font12">Supplementary </span>
   <span class="font12">activity </span>
   <span class="font12">effector </span>
   <span class="font12">group </span>
   <span class="font12">lung </span>
   <span class="font12">nanobody-Fc </span>
   <span class="font12">pandemic </span>
   <span class="font12">stem </span>
   <span class="font12">Ra-B-mIgG, </span>
   <span class="font12">control </span>
   <span class="font12">culled </span>
   <span class="font12">injection </span>
   <span class="font12">vitro </span>
   <span class="font12">CA/ </span>
   <span class="font12">HAI </span>
   <span class="font12">Ra-B-mIgGa, </span>
   <span class="font12">cAb-mIgGa </span>
   <span class="font12">complete </span>
   <span class="font12">previously </span>
   <span class="font12">provide </span>
   <span class="font12">showed </span>
   <span class="font12">tested </span>
   <span class="font12">D). </span>
   <span class="font12">Immunol. </span>
   <span class="font12">Influenza </span>
   <span class="font12">Med. </span>
   <span class="font12">dilution </span>
   <span class="font12">highly </span>
   <span class="font12">lethal </span>
   <span class="font12">loss </span>
   <span class="font12">low </span>
   <span class="font12">mAbs </span>
   <span class="font12">monoclonal </span>
   <span class="font12">monovalent </span>
   <span class="font12">prophylactic </span>
   <span class="font12">received </span>
   <span class="font12">specific </span>
   <span class="font12">weight </span>
   <span class="font11">Ra-B-mIgG </span>
   <span class="font11">Table </span>
   <span class="font11">able </span>
   <span class="font11">conserved </span>
   <span class="font11">cross-subtype </span>
   <span class="font11">described </span>
   <span class="font11">expressed </span>
   <span class="font11">fusions </span>
   <span class="font11">high </span>
   <span class="font11">intramuscular </span>
   <span class="font11">mediated </span>
   <span class="font11">new </span>
   <span class="font11">post-challenge </span>
   <span class="font11">potent </span>
   <span class="font11">potential </span>
   <span class="font11">px; </span>
   <span class="font11">response </span>
   <span class="font11">symptoms </span>
   <span class="font11">used </span>
   <span class="font11">{font-family </span>
   <span class="font11">(data </span>
   <span class="font11">A(HN) </span>
   <span class="font11">IgG </span>
   <span class="font11">IgGa </span>
   <span class="font11">MLD </span>
   <span class="font11">added </span>
   <span class="font11">addition, </span>
   <span class="font11">additional </span>
   <span class="font11">adeno-associated </span>
   <span class="font11">bind </span>
   <span class="font11">broadly </span>
   <span class="font11">cAb-mIgGa, </span>
   <span class="font11">clinical </span>
   <span class="font11">concentration </span>
   <span class="font11">detected </span>
   <span class="font11">font-size </span>
   <span class="font11">interactions </span>
   <span class="font11">level </span>
   <span class="font11">measured </span>
   <span class="font11">nanobodies </span>
   <span class="font11">seen </span>
   <span class="font11">shown). </span>
   <span class="font11">subtypes </span>
   <span class="font11">therapy </span>
   <span class="font11">weeks </span>
   <span class="font11">(HN) </span>
   <span class="font11">A), </span>
   <span class="font11">BALB/c </span>
   <span class="font11">Biological </span>
   <span class="font11">Division </span>
   <span class="font11">FcγR </span>
   <span class="font11">Figure </span>
   <span class="font11">Health </span>
   <span class="font11">Institute </span>
   <span class="font11">Plates </span>
   <span class="font11">avian </span>
   <span class="font11">circulation </span>
   <span class="font11">compared </span>
   <span class="font11">dependent </span>
   <span class="font11">development </span>
   <span class="font11">dose </span>
   <span class="font11">double; </span>
   <span class="font11">end </span>
   <span class="font11">format </span>
   <span class="font11">genome </span>
   <span class="font11">hemagglutinin </span>
   <span class="font11">higher </span>
   <span class="font11">infiltration </span>
   <span class="font11">intranasal </span>
   <span class="font11">lungs </span>
   <span class="font11">muscle </span>
   <span class="font11">natural </span>
   <span class="font11">need </span>
   <span class="font11">potency </span>
   <span class="font11">rAAV </span>
   <span class="font11">ranging </span>
   <span class="font11">studies </span>
   <span class="font11">thickening </span>
   <span class="font11">transgenes </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">(A) </span>
   <span class="font11">./fimmu.. </span>
   <span class="font11">:e. </span>
   <span class="font11">A(HN), </span>
   <span class="font11">A/Vietnam// </span>
   <span class="font11">ELISA </span>
   <span class="font11">FIGURE </span>
   <span class="font11">Gene </span>
   <span class="font11">HN, </span>
   <span class="font11">However, </span>
   <span class="font11">Kingdom[], </span>
   <span class="font11">National </span>
   <span class="font11">Opin </span>
   <span class="font11">Standards </span>
   <span class="font11">Ther. </span>
   <span class="font11">University </span>
   <span class="font11">affinity </span>
   <span class="font11">anti-influenza </span>
   <span class="font11">antigen </span>
   <span class="font11">article </span>
   <span class="font11">blood </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">broad </span>
   <span class="font11">bronchioles </span>
   <span class="font11">constructs </span>
   <span class="font11">contrast, </span>
   <span class="font11">cross-neutralizing </span>
   <span class="font11">delivered </span>
   <span class="font11">delivery. </span>
   <span class="font11">determine </span>
   <span class="font11">determined </span>
   <span class="font11">dilutions </span>
   <span class="font11">effective </span>
   <span class="font11">epitope </span>
   <span class="font11">evaluate </span>
   <span class="font11">fragment </span>
   <span class="font11">half-life </span>
   <span class="font11">immunoprophylaxis </span>
   <span class="font11">incubated </span>
   <span class="font11">independent </span>
   <span class="font11">inflammation </span>
   <span class="font11">intranasally </span>
   <span class="font11">line </span>
   <span class="font11">long </span>
   <span class="font11">lower </span>
   <span class="font11">method </span>
   <span class="font11">model </span>
   <span class="font11">negative </span>
   <span class="font11">post-AAV </span>
   <span class="font11">present </span>
   <span class="font11">receiving </span>
   <span class="font11">reported </span>
   <span class="font11">represent </span>
   <span class="font11">samples </span>
   <span class="font11">serotype </span>
   <span class="font11">solid; </span>
   <span class="font11">strain </span>
   <span class="font11">structure </span>
   <span class="font11">suggests </span>
   <span class="font11">systemic </span>
   <span class="font11">taken </span>
   <span class="font11">terminal </span>
   <span class="font11">therapeutic </span>
   <span class="font11">titers </span>
   <span class="font11">transfer </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(B) </span>
   <span class="font10">(Figures </span>
   <span class="font10">(Supplementary </span>
   <span class="font10">-days </span>
   <span class="font10">.). </span>
   <span class="font10">./.. </span>
   <span class="font10">./journal.pone. </span>
   <span class="font10">A). </span>
   <span class="font10">Assay </span>
   <span class="font10">B). </span>
   <span class="font10">CA/. </span>
   <span class="font10">Control </span>
   <span class="font10">Delivery </span>
   <span class="font10">Engl </span>
   <span class="font10">Expression </span>
   <span class="font10">Mouse </span>
   <span class="font10">NIBRG-ma </span>
   <span class="font10">NIBRG-ma. </span>
   <span class="font10">Nanobodies </span>
   <span class="font10">One. </span>
   <span class="font10">Scientific </span>
   <span class="font10">Viral </span>
   <span class="font10">World </span>
   <span class="font10">ability </span>
   <span class="font10">absence </span>
   <span class="font10">activity. </span>
   <span class="font10">administration </span>
   <span class="font10">air </span>
   <span class="font10">animal </span>
   <span class="font10">approach </span>
   <span class="font10">arm </span>
   <span class="font10">bold </span>
   <span class="font10">capable </span>
   <span class="font10">carried </span>
   <span class="font10">chains </span>
   <span class="font10">challenge, </span>
   <span class="font10">concentrations </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">day </span>
   <span class="font10">diluted </span>
   <span class="font10">doses </span>
   <span class="font10">duration </span>
   <span class="font10">em; </span>
   <span class="font10">enhance </span>
   <span class="font10">epitopes </span>
   <span class="font10">extended </span>
   <span class="font10">extension </span>
   <span class="font10">functions </span>
   <span class="font10">hemagglutination </span>
   <span class="font10">highest </span>
   <span class="font10">histological </span>
   <span class="font10">host </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">individual </span>
   <span class="font10">induced </span>
   <span class="font10">injection. </span>
   <span class="font10">isotypes </span>
   <span class="font10">key </span>
   <span class="font10">maximum </span>
   <span class="font10">mechanism </span>
   <span class="font10">mechanisms </span>
   <span class="font10">membrane </span>
   <span class="font10">months </span>
   <span class="font10">neutralize </span>
   <span class="font10">observed </span>
   <span class="font10">obtained </span>
   <span class="font10">overnight </span>
   <span class="font10">passive </span>
   <span class="font10">patient </span>
   <span class="font10">perivascular </span>
   <span class="font10">point </span>
   <span class="font10">post </span>
   <span class="font10">pre-challenge </span>
   <span class="font10">production </span>
   <span class="font10">protect </span>
   <span class="font10">protective </span>
   <span class="font10">protein </span>
   <span class="font10">proteins </span>
   <span class="font10">pseudotypes </span>
   <span class="font10">pt;} </span>
   <span class="font10">reactivity </span>
   <span class="font10">receptor </span>
   <span class="font10">recombinant </span>
   <span class="font10">reformatted </span>
   <span class="font10">relative </span>
   <span class="font10">represents </span>
   <span class="font10">required </span>
   <span class="font10">significant </span>
   <span class="font10">stable </span>
   <span class="font10">standard </span>
   <span class="font10">study, </span>
   <span class="font10">sufficient </span>
   <span class="font10">survived </span>
   <span class="font10">sustained </span>
   <span class="font10">test </span>
   <span class="font10">time </span>
   <span class="font10">titer </span>
   <span class="font10">triple </span>
   <span class="font10">two-fold </span>
   <span class="font10">use </span>
   <span class="font10">vaccine </span>
   <span class="font10">vaccines </span>
   <span class="font10">values </span>
  </p>
 </body>
</html>
